166 related articles for article (PubMed ID: 31435238)
21. Constitutional BRCA1 Methylation and Risk of Incident Triple-Negative Breast Cancer and High-grade Serous Ovarian Cancer.
Lønning PE; Nikolaienko O; Pan K; Kurian AW; Eikesdal HP; Pettinger M; Anderson GL; Prentice RL; Chlebowski RT; Knappskog S
JAMA Oncol; 2022 Nov; 8(11):1579-1587. PubMed ID: 36074460
[TBL] [Abstract][Full Text] [Related]
22. Promoter Methylation Status of Breast Cancer Susceptibility Gene 1 and 17 Beta Hydroxysteroid Dehydrogenase Type 1 Gene in Sporadic Breast Cancer Patients.
Hosny MM; Sabek NA; El-Abaseri TB; Hassan FM; Farrag SH
Int J Breast Cancer; 2016; 2016():9545241. PubMed ID: 27413552
[TBL] [Abstract][Full Text] [Related]
23. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
Gupta S; Jaworska-Bieniek K; Narod SA; Lubinski J; Wojdacz TK; Jakubowska A
Breast Cancer Res Treat; 2014 Dec; 148(3):615-22. PubMed ID: 25376744
[TBL] [Abstract][Full Text] [Related]
25. BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.
Otani Y; Miyake T; Kagara N; Shimoda M; Naoi Y; Maruyama N; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Cancer Sci; 2014 Oct; 105(10):1369-76. PubMed ID: 25155055
[TBL] [Abstract][Full Text] [Related]
26. Analysis of
Tabano S; Azzollini J; Pesenti C; Lovati S; Costanza J; Fontana L; Peissel B; Miozzo M; Manoukian S
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32276467
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
[TBL] [Abstract][Full Text] [Related]
28. The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis.
Li S; He Y; Li C; Liu X; Shen Y; Wu Y; Bai N; Li Q
Medicine (Baltimore); 2020 Mar; 99(10):e19345. PubMed ID: 32150073
[TBL] [Abstract][Full Text] [Related]
29. Curcumin induces re‑expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines.
Al-Yousef N; Shinwari Z; Al-Shahrani B; Al-Showimi M; Al-Moghrabi N
Oncol Rep; 2020 Mar; 43(3):827-838. PubMed ID: 32020216
[TBL] [Abstract][Full Text] [Related]
30. Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features.
Shakeri H; Fakhrjou A; Nikanfar A; Mohaddes-Ardebili SM
Clin Lab; 2016 Dec; 62(12):2333-2337. PubMed ID: 28164568
[TBL] [Abstract][Full Text] [Related]
31. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
32. High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients.
Chen J; Haanpää MK; Gruber JJ; Jäger N; Ford JM; Snyder MP
Clin Cancer Res; 2019 Sep; 25(17):5301-5314. PubMed ID: 31175093
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of BRCA1 gene associated with demographic and pathologic factors in sporadic breast cancer: a study of an Indian population.
Singh AK; Pandey A; Tewari M; Shukla HS; Pandey HP
Eur J Cancer Prev; 2011 Nov; 20(6):478-83. PubMed ID: 21572332
[TBL] [Abstract][Full Text] [Related]
34. Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women.
Saif I; Bouziyane A; Benhessou M; Karroumi ME; Ennaji MM
Mol Biol Rep; 2021 Nov; 48(11):7147-7152. PubMed ID: 34591267
[TBL] [Abstract][Full Text] [Related]
35. Promoter Hypermethylation in White Blood Cell DNA and Breast Cancer Risk.
Cho YH; McCullough LE; Gammon MD; Wu HC; Zhang YJ; Wang Q; Xu X; Teitelbaum SL; Neugut AI; Chen J; Santella RM
J Cancer; 2015; 6(9):819-24. PubMed ID: 26284132
[TBL] [Abstract][Full Text] [Related]
36. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
Xu X; Gammon MD; Zhang Y; Bestor TH; Zeisel SH; Wetmur JG; Wallenstein S; Bradshaw PT; Garbowski G; Teitelbaum SL; Neugut AI; Santella RM; Chen J
Breast Cancer Res Treat; 2009 May; 115(2):397-404. PubMed ID: 18521744
[TBL] [Abstract][Full Text] [Related]
37. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.
Jin W; Chen L; Chen Y; Xu SG; Di GH; Yin WJ; Wu J; Shao ZM
Breast Cancer Res Treat; 2010 Sep; 123(2):359-73. PubMed ID: 19943104
[TBL] [Abstract][Full Text] [Related]
38. Gene promoter methylation is associated with increased mortality among women with breast cancer.
Xu X; Gammon MD; Zhang Y; Cho YH; Wetmur JG; Bradshaw PT; Garbowski G; Hibshoosh H; Teitelbaum SL; Neugut AI; Santella RM; Chen J
Breast Cancer Res Treat; 2010 Jun; 121(3):685-92. PubMed ID: 19921426
[TBL] [Abstract][Full Text] [Related]
39. Pyrosequencing quantified methylation level of BRCA1 promoter as prognostic factor for survival in breast cancer patient.
Cai FF; Chen S; Wang MH; Lin XY; Zhang L; Zhang JX; Wang LX; Yang J; Ding JH; Pan X; Shao ZM; Biskup E
Oncotarget; 2016 May; 7(19):27499-510. PubMed ID: 27027444
[TBL] [Abstract][Full Text] [Related]
40. CLINICAL SIGNIFICANCE OF BRCA1 GENE SEQUENCING AND ITS PROMOTER METHYLATION TESTING IN THE SEARCH STRATEGY FOR THERAPEUTIC TARGETS IN BREAST CANCER TREATMENT.
Fishchuk L; Lobanova O; Rossokha Z; Cheshuk V; Vereshchako R; Vagyn Y; Kashuba V; Vershyhora V; Popova O; Levkovich N; Zemlianska O; Ievseienkova O; Podolska S; Gorovenko N
Exp Oncol; 2023 Oct; 45(2):161-169. PubMed ID: 37824776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]